基于天然和合成凝的胆汁酸封存剂
Magdalena-Cristina Stanciu1, Marieta Nichifor1, Carmen-Alice Teacă2
1Natural Polymers, Bioactive and Biocompatible Materials Department, "Petru Poni" Institute of Macromolecular Chemistry, 41A, Gr. Ghica-Voda Alley, 700487 Iasi, Romania.
Gels (Basel, Switzerland)
|June 27, 2023
概括
胆汁酸结合剂 (BAS) 是安全的,非全身性药物,通过结合肠道中的胆汁盐来控制高胆固醇. 本综述详细介绍了BAS,它们的合成,以及它们降低脂质的有效性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 聚合物化学 聚合物化学
- 生物化学 生物化学
背景情况:
- 胆酸分离剂 (BAS) 是用于高胆固醇血症管理的非系统性药物.
- 它们通过结合小肠中的胆盐来起作用,防止再吸收并促进分泌.
- 一般来说,BAS因其安全性和最小的系统性不良影响而得到认可.
研究的目的:
- 为提供胆汁酸和胆汁酸分离剂的全面概述.
- 详细介绍商业和潜在BAS的特性,作用机制和化学结构.
- 探索聚合物结构和胆盐结合亲和力之间的关系.
主要方法:
- 审查有关胆酸和胆酸的现有文献.
- 对第一代和第二代BAS的化学结构和合成方法的分析.
- 检查新型BAS候选物,包括合成聚合物和生物聚合物,以及分子印记聚合物 (MIP).
主要成果:
- 商业BAS包括第一代 (胆固醇胺,科莱克斯坦,科莱斯蒂波尔) 和第二代 (科莱塞维拉姆,科莱斯蒂兰).
- 潜在的BAS基于各种聚合物,如聚甲烯酸/烯胺),纤维素和环氧.
- 分子印记聚合物 (MIP) 对胆盐结合具有很高的选择性和亲和力.
结论:
- 了解结构-活动关系对于开发有效的BAS至关重要.
- 各种基于合成和生物聚合物的BAS为高胆固醇血症治疗提供了潜力.
- 该审查涵盖了合成途径,并评估了体外和体外的低脂性活动.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
706
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
706
Lipid Absorption
542
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
542
Glucagon-like Receptor Agonists
366
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
366
Drugs Affecting GI Tract Motility: Other Laxatives
285
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
285
Hepatic Drug Excretion: Influencing Factors
164
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
164
Lipid Digestion
92.3K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
92.3K


